Chimera Investment (NYSE:CIM) Azioni

Chimera Investment

Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.

Financial,Freedom,With,Large,Amounts,Of,Money,Invested,In,Index

Long Ideas

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

Tre titoli del settore finanziario con rendimenti da dividendo eccezionali sono sotto la lente di analisti di rilievo. Ecco di chi si tratta.

Dividendi alle stelle: 3 azioni di Wall Street che pagano una fortuna

Chimera Investment Corporation Common Stock

Chimera Investment Corp

CIMB GROUP HLDGS BHD ORD by CIMB Group Holdings BHD

CIMB Group Holdings Bhd

CIMC ENRIC HLDGS LTD ORD by CIMC Enric Holdings Ltd.

CIMC Enric Holdings Ltd

Chimera Investment Corporation 9.000% Senior Notes due 2029

Chimera Investment Corporation 9.250% Senior Notes due 2029

CIMAREX ENERGY 8 1/8 PFD by Cimarex Energy Co.

Chimera Investment Corporation 8.00% Series A Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 7.75% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

Chimera Investment Corporation 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

UBS analyst Douglas Harter maintains Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) with a Buy and raises the price target from $15 to $16.

UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

Keefe, Bruyette &amp; Woods analyst Bose George maintains Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) with a Market Perform and lowers the price target from $16.5 to $15.

Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">Arbor Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 11.21%</li>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained a Market Perform rating and cut the price target from $11.75 to $11 on May 6, 2025. This analyst has an accuracy rate of 68%.</li>
<li>JP Morgan analyst Richard Shane maintained an Underweight rating and cut the price target from $10.5 to $10 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 2, Arbor Realty Trust posted mixed quarterly results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest ABR <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702"><img loading="lazy" decoding="async" width="907" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045826/image-20.png" alt="" class="wp-image-969972" style="width:698px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045826/image-20.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045826/image-20-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045826/image-20-768x692.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">The Western Union Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 11.16%</li>
<li>UBS analyst Timothy Chiodo maintained a Neutral rating and lowered the price target from $11 to $10.5 on April 24, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintained a Market Perform rating and slashed the price target from $12 to $11 on April 24, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On April 23, Western Union posted in-line quarterly earnings.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest WU <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702"><img loading="lazy" decoding="async" width="923" height="833" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045850/image-21.png" alt="" class="wp-image-969973" style="width:605px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045850/image-21.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045850/image-21-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045850/image-21-768x693.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<h3 class="wp-block-heading">Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 10.67%</li>
<li>UBS analyst Douglas Harter upgraded the stock from Neutral to Buy and raised the price target from $11.5 to $15 on May 14, 2025. This analyst has an accuracy rate of 69%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained a Market Perform rating and raised the price target from $15 to $16 on Aug. 8, 2024. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: On June 12, HomeXpress Mortgage Corp. agreed to be acquired by Chimera Investment Corporation.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702">CIM news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0702"><img loading="lazy" decoding="async" width="918" height="812" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045918/image-22.png" alt="" class="wp-image-969978" style="width:534px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045918/image-22.png 918w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045918/image-22-300x265.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02045918/image-22-768x679.png 768w" sizes="(max-width: 918px) 100vw, 918px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a> </li>
</ul>
Photo via Shutterstock

Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields

HomeXpress Mortgage Corp. ("HomeXpress"), a leading national originator of non-QM and business-purpose residential mortgage loans, today announced that it has entered into a definitive agreement to be acquired by Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) ("Chimera") from certain affiliates of Seer Capital Management's credit fund business ("Seer") and certain management sellers.
HomeXpress will operate as a subsidiary of Chimera under the continuing leadership of President and CEO Kyle Walker and the experienced HomeXpress management team.

HomeXpress Mortgage To Be Acquired By Chimera Investment Corp In Definitive Agreement; No Financial Terms Disclosed

Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) announced Thursday it will acquire HomeXpress Mortgage Corp., a non-QM and non-agency loan originator with a nationwide footprint <a href="https://www.benzinga.com/pressreleases/25/06/b45900081/chimera-investment-corporation-nyse-cim-chimera-announces-definitive-agreement-to-acquire-homexpre">spanning 46 states and Washington, D.C</a>.
The deal, signed on June 11, includes a payment of $120 million in cash and 2,077,151 shares of Chimera stock. It will be executed through Chimera's taxable REIT subsidiary, Chimera Funding TRS.
The acquisition will expand Chimera's access to mortgage loan origination and strengthen its securitization and servicing operations, aligning with its long-term growth strategy. The transaction is expected to close in the fourth quarter of 2025.
Also Read: <a href="https://www.benzinga.com/real-estate/25/06/45831855/gen-z-turns-to-siblings-and-side-hustles-to-afford-homes-amid-soaring-prices">Gen Z Turns To Siblings And Side Hustles To Afford Homes Amid Soaring Prices</a>
Chimera anticipates the deal will be earnings-accretive beginning in 2026. HomeXpress has operated profitably since its founding in 2016, generating $47 million in pre-tax income in 2024. 
The company originated $2.5 billion in loans last year and projects $3.5 billion in volume for 2025, supported by its strong broker and correspondent partner network.
Following the acquisition, HomeXpress will continue as a wholly owned subsidiary, with CEO Kyle Walker and his senior leadership team staying on to lead the business.
Chimera also plans to leverage existing net operating losses to offset the acquisition premium. It will gain additional revenue streams through origination fees and gain-on-sale income, helping diversify its earnings base.
CIM held cash and cash equivalents of <a href="https://www.benzinga.com/pressreleases/25/05/b45280351/chimera-investment-corporation-reports-1st-quarter-2025-earnings" target="_blank" rel="noreferrer noopener">$253.349 million</a> as of March 31, 2025.
Other companies involved in the residential and mortgage sector include PennyMac Financial Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) and Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>).
Investors may also watch mortgage-focused ETFs, such as the iShares MBS ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBB#NASDAQ">MBB</a>) and the VanEck Mortgage REIT Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MORT#NYSE">MORT</a>).
Price Action: CIM shares are trading lower by 0.22% to $13.89 premarket at last check Thursday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45900930/gold-surpasses-euro-to-become-second-largest-reserve-asset-still-far-behind-dollar-ecb-says" target="_blank" rel="noreferrer noopener">Gold Surpasses Euro To Become Second-Largest Reserve Asset, Still Far Behind Dollar, ECB Says</a></li>
</ul>
Photo by Gumbariya via Shutterstock

MORT

PFSI

Chimera Expands Mortgage Reach With HomeXpress Acquisition

Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) ("Chimera") today announced that on June 11, 2025, it entered into a definitive agreement to acquire HomeXpress Mortgage Corp. ("HomeXpress") from certain affiliates of Seer Capital Management's credit fund business ("Seer") and certain management sellers (together with Seer, the "Sellers"). HomeXpress is a leading originator of consumer non-QM, investor business purpose, and other non-Agency mortgage loan products, as well as an originator of Agency mortgage loans with a nationwide presence across 46 states and D.C.
"We are thrilled to welcome HomeXpress to the Chimera team," said Phillip J. Kardis II, President and Chief Executive Officer of Chimera. "We believe that the transaction is the natural next step in the transformation of Chimera. Bringing together Chimera's strong history of loan securitization, structured finance, and third-party loan management and advisory services with HomeXpress' loan origination platform is expected to create a powerful combination and enhance our enterprise value. HomeXpress has an excellent management team with experienced origination professionals that have a long history of serving broker and correspondent partners across the U.S. We expect this acquisition to be accretive to Chimera's earnings in 2026."
Strategic Rationale and Benefits to Chimera Shareholders
<ul>
<li>Highly Synergistic with Chimera's Platform
<ul>
<li>The combination of HomeXpress' non-QM origination platform and our loan management and advisory services is expected to create a tremendous cross-selling opportunity.</li>
<li>Provides opportunity for Chimera to acquire and securitize loans on a direct basis.</li>
<li>Supports Chimera's efforts to build an MSR portfolio.</li>
<li>Presents an opportunity to create enterprise value at the platform level.</li>
</ul>
</li>
<li>Attractive and Diverse Returns
<ul>
<li>Existing net operating losses at Chimera are expected to cover a substantial amount of the acquisition premium.</li>
<li>Continues the diversification of Chimera's income streams to include origination fees and gain on sale income.</li>
</ul>
</li>
</ul>
HomeXpress Highlights
<ul>
<li>A leading national non-QM originator</li>
<li>Approximately 300 employees and lending in 46 states and D.C.</li>
<li>$2.5 billion UPB of funded origination volume in 2024</li>
<li>$3.5 billion UPB of estimated origination volume for the full year 2025, with $1.2 billion UPB of year-to-date funded origination volume through May 2025</li>
<li>Made first loan in 2016 and has been profitable every year since</li>
<li>2024 pre-tax net income of $47 million</li>
<li>$115 million of GAAP Total Equity as of March 31, 2025</li>
<li>Partner of choice for brokers and correspondent lenders across U.S.</li>
<li>Experienced management team</li>
</ul>
Key Transaction Details
Under the terms of the agreement, Chimera will cause its taxable REIT subsidiary, Chimera Funding TRS, to acquire HomeXpress from the Sellers for a combination of cash and 2,077,151 shares of Chimera common stock. The purchase price will be equal to the adjusted book value of HomeXpress as of the end of the month prior to the closing, plus a premium consisting of $120 million in cash plus 2,077,151 shares of Chimera common stock. HomeXpress will operate as a subsidiary of Chimera and Kyle Walker, the current President and CEO, along with key members of the senior management team will continue to manage HomeXpress. Chimera expects to close the transaction during the fourth quarter of 2025, subject to the satisfaction of customary closing conditions.

Chimera to Acquire HomeXpress for $120M Plus 2.08M Shares to Expand Loan Origination

In the current session, the stock is trading at $13.38, after a 1.52% increase. Over the past month, Chimera Investment Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) stock increased by 8.75%, and in the past year, by 10.59%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1748887218_0.png" alt="Past Year Chart" />

<h3>Evaluating Chimera Investment P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Chimera Investment has a lower P/E than the aggregate P/E of 17.32 of the Mortgage Real Estate Investment Trusts (REITs) industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748887218_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Chimera Investment

UBS analyst Douglas Harter upgrades Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) from Neutral to Buy and raises the price target from $11.5 to $15.

Upgrades

UBS Upgrades Chimera Investment to Buy, Raises Price Target to $15

Earnings

Chimera Investment Q1 Adj. EPS $0.41 Beats $0.40 Estimate, Sales $69.22M Miss $72.07M Estimate

AAOI

ABCL

ABEV

ACIC

ACIW

ACMR

ACTG

AFRM

AKAM

AKBA

ALGM

ALIT

ALRM

ALXO

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AMPX

AMTX

APPN

APYX

AQMS

ARGX

ARHS

ARKO

ARLO

ASPN

ASTH

Adtalem Global Education Inc. Common Stock

ATGE

ATHM

ATUS

AUTL

AVAH

AVPT

AXGN

BAER

BBDC

BIGC

BILL

BIRD

BlackSky Technology Inc. Class A Common Stock

BKSY

BLFS

BLND

CARG

CARS

CBLL

CBUS

CCEC

CCOI

CCRD

CDTX

CION

CLAR

CLFD

CLNE

CLSK

CMPS

CMRE

CODX

COIN

COLD

COLL

COMP

CRNX

CRON

CROX

CRVS

CTEV

CTKB

CTLP

CVRX

DAVE

DCGO

DCTH

DIOD

DKNG

Earnings Scheduled For May 8, 2025

WIIM

AFCG

BXMT

CFFI

CMTG

CODI

FUNC

GLAD

GPMT

OVBC

RITM

SBCF

STWD

TCBX

TRMK

Shares of broader financial companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by <a href="https://www.benzinga.com/government/regulations/25/02/43656846/inflation-rises-more-than-expected-in-january-chills-interest-rate-cut-hopes">midday trading in New York.</a>
The S&amp;P 500 was down 0.2%, while the Nasdaq 100 was flat, both rebounding from sharp declines following the January Consumer Price Index report. Small-cap stocks underperformed, with the Russell 2000 slipping 0.8%.
The headline CPI rose 3% year over year in January, surpassing both December's 2.9% reading and economist forecasts of 2.9%. On a monthly basis, inflation increased 0.5%, outpacing expectations of 0.3% and accelerating from December's 0.4% gain. This marked the fastest monthly inflation rate since August 2023.
Core inflation, which excludes food and energy, climbed to 3.3% year over year from 3.2% in December. On a monthly basis, core CPI increased 0.4%, exceeding estimates of 0.3% and doubling December's 0.2% rise.
Treasuries and interest rate markets reacted sharply to the inflation data. Traders scaled back expectations for Federal Reserve rate cuts, now projecting only one reduction by December 2025.
Treasury yields surged, reflecting heightened investor uncertainty. The 10-year Treasury yield jumped 10 basis points to 4.64%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 1%.
Despite rising Treasury yields and a stronger dollar, gold edged up 0.2% to $2,910 per ounce. Oil prices dropped 2% after reports that Donald Trump spoke with Russian President Vladimir Putin, fueling speculation about a potential ceasefire in Ukraine.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) also rebounded from earlier session losses.
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,688.40</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,056.85</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,411.00</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,257.59</td>
<td>-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;inched 0.2% down to $603.77.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was 0.4% down to $444.41.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;flattened at $528.09.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.8% to $224.</li>
<li>The&nbsp;Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 0.4%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.2%.</li>
</ul>
Wednesday&#8217;s Stock Movers
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) jumped more than 4% after the electric vehicle maker tumbled 6.3% on Tuesday, reaching oversold levels and extending its losing streak to five consecutive sessions.</li>
</ul>
Stocks reacting to company earnings reports included: 
<ul>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>): up 15.7%</li>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>): up 4.5%</li>
<li>Edwards Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>): up 5.6%</li>
<li>América Móvil, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>): down 1.4%</li>
<li>American International Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>): up 0.2%</li>
<li>Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>): up 0.3%</li>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>): up 2.9%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): up 6.8%</li>
<li>Zillow Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>): down 10.2%</li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>): up 2.2%</li>
<li>Chimera Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>): down 8.9%</li>
<li>Ryder System Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>): up 4.0%</li>
<li>Smurfit WestRock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>): down 5.8%</li>
<li>Sonic Automotive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>): down 2.4%</li>
<li>Alkermes Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>): up 4.1%</li>
<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>): up 1.0%</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>): down 4.6%</li>
<li>Blackstone Mortgage Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXMT#NYSE">BXMT</a>): up 2.8%</li>
<li>Camtek Ltd/Israel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>): up 1.5%</li>
<li>Chefs' Warehouse Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>): up 13.0%</li>
<li>Diebold Nixdorf Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>): down 3.2%</li>
<li>Dominion Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>): up 0.6%</li>
<li>Exelon Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>): up 0.4%</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january">Record-High Egg Prices Drive Inflation Higher In January</a></li>
</ul>
Illustration created using artificial intelligence via Midjourney.

Equities

Large Cap

Commodities

Economics

Federal Reserve

Tech

ETFs

$BTC

ALKS

AVXL

BIIB

CAMT

CHEF

SPDR Dow Jones Industrial Average ETF Trust

GILD

SCCO

SMCI

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

Chimera Investment shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS and revenue estimates.

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.47 by 21.28 percent. This is a 184.62 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $65.82 million which missed the analyst consensus estimate of $77.55 million by 15.12 percent. This is a 1.81 percent increase over sales of $64.65 million the same period last year.

Earnings Misses

Chimera Investment Q4 2024 Sales $65.82M Miss $77.55M Estimate

Chimera Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.47 by 21.28 percent.&nbsp;

Chimera Investment Q4 2024 Adj EPS $0.37 Misses $0.47 Estimate

ACRE

AEIS

AEMD

ALCO

AMWL

ASND

ATRC

AYTU

BROS

CGNX

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CSCO

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

Earnings Scheduled For February 12, 2025

Comments

Chimera Investment

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO